Effects of the new angiotensin-converting enzyme inhibitor, ramipril, in patients with essential hypertension (Q70144767)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3016405%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

title

Effects of the new angiotensin-converting enzyme inhibitor, ramipril, in patients with essential hypertension (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3016405%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

main subject

essential hypertension

1 reference

K O Stumpe

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3016405%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

A Overlack

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3016405%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

R Kolloch

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3016405%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

J Schatz

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3016405%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

P U Witte

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3016405%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

K Pahnke

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3016405%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

publication date

1 June 1986

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3016405%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

published in

Klinische Wochenschrift

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3016405%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

volume

64

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3016405%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3016405%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

page(s)

558-562

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3016405%20AND%20SRC:MED&resulttype=core&format=json

Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects

9 October 2019

cites work

1 reference

12 December 2020

Angiotensin Converting-Enzyme Inhibitor in Refractory Hypertension

1 reference

12 December 2020

Captopril compared with other antirenin system agents in hypertensive patients: its triphasic effects on blood pressure and its use to identify and treat the renin factor

1 reference

12 December 2020

Effects of the new oral angiotensin converting enzyme inhibitor 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S,5S)-2- azabicyclo[3.3.0]octane-3-carboxylic acid (Hoe 498) in essential hypertension

1 reference

12 December 2020

Long-term antihypertensive therapy with captopril

1 reference

12 December 2020

A new class of angiotensin-converting enzyme inhibitors

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of a novel orally active angiotensin converting enzyme inhibitor (HOE 498) in healthy subjects

1 reference

12 December 2020

Acute and chronic effects of the angiotensin-converting enzyme inhibitor captopril in severe hypertension

1 reference

12 December 2020

Low-dose captopril for the treatment of mild to moderate hypertension

1 reference

12 December 2020

Design of potent competitive inhibitors of angiotensin-converting enzyme. Carboxyalkanoyl and mercaptoalkanoyl amino acids

1 reference

12 December 2020

Cardiovascular and antihypertensive activities of the novel non-sulfhydryl converting enzyme inhibitor 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S,5S)-2- azabicyclo[3.3.0]octane-3-carboxylic acid (Hoe 498)

1 reference

12 December 2020

Tolerance and pharmacodynamics of the angiotensin converting enzyme inhibitor 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S,5S)-2- azabicyclo[3.3.0]octane-3-carboxylic acid (Hoe 498) in healthy volunteers

1 reference

12 December 2020

Spectrophotometric assay and properties of the angiotensin-converting enzyme of rabbit lung

1 reference

12 December 2020

Pharmacological properties of the new orally active angiotensin converting enzyme inhibitor 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl] -(1S,3S,5S)-2-azabicyclo[3.3.0]octane-3-carboxylic acid (Hoe 498)

1 reference

12 December 2020

The clinical pharmacology of enalapril

1 reference

12 December 2020

Long-term efficacy of angiotensin-converting-enzyme inhibition with captopril in mild-to-moderate essential hypertension

1 reference

12 December 2020

Mechanisms regulating renin release

1 reference

12 December 2020

Haemodynamics of Orally-Active Converting Enzyme Inhibitor (SQ 14225) in Hypertensive Patients

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01735319

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3016405%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

1 reference